Literature DB >> 28961382

Characterization and stratification of prostate lesions based on comprehensive multiparametric MRI using detailed whole-mount histopathology as a reference standard.

Olga Starobinets1,2, Jeffry P Simko3,4, Kyle Kuchinsky3, John Kornak5, Peter R Carroll4, Kirsten L Greene4, John Kurhanewicz1,2, Susan M Noworolski1,2.   

Abstract

The purpose of this study was to characterize prostate cancer (PCa) based on multiparametric MR (mpMR) measures derived from MRI, diffusion, spectroscopy, and dynamic contrast-enhanced (DCE) MRI, and to validate mpMRI in detecting PCa and predicting PCa aggressiveness by correlating mpMRI findings with whole-mount histopathology. Seventy-eight men with untreated PCa received 3 T mpMR scans prior to radical prostatectomy. Cancerous regions were outlined, graded, and cancer amount estimated on whole-mount histology. Regions of interest were manually drawn on T2 -weighted images based on histopathology. Logistic regression was used to identify optimal combinations of parameters for the peripheral zone and transition zone to separate: (i) benign from malignant tissues; (ii) Gleason score (GS) ≤3 + 3 disease from ≥GS3 + 4; and (iii) ≤ GS3 + 4 from ≥GS4 + 3 cancers. The performance of the models was assessed using repeated fourfold cross-validation. Additionally, the performance of the logistic regression models created under the assumption that one or more modality has not been acquired was evaluated. Logistic regression models yielded areas under the curve (AUCs) of 1.0 and 0.99 when separating benign from malignant tissues in the peripheral zone and the transition zone, respectively. Within the peripheral zone, combining choline, maximal enhancement slope, apparent diffusion coefficient (ADC), and citrate measures for separating ≤GS3 + 3 from ≥GS3 + 4 PCa yielded AUC = 0.84. Combining creatine, choline, and washout slope yielded AUC = 0.81 for discriminating ≤GS3 + 4 from ≥GS4 + 3 disease. Within the transition zone, combining washout slope, ADC, and creatine yielded AUC = 0.93 for discriminating ≤GS3 + 3 and ≥GS3 + 4 cancers. When separating ≤GS3 + 4 from ≥GS4 + 3 PCa, combining choline and washout slope yielded AUC = 0.92. MpMRI provides excellent separation between benign tissues and PCa, and across PCa tissues of different aggressiveness. The final models prominently feature spectroscopy and DCE-derived metrics, underlining their value within a comprehensive mpMRI examination.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  diffusion-weighted imaging; dynamic contrast-enhanced imaging; histopathology; magnetic resonance spectroscopy imaging; multiparametric MRI; prostate cancer

Mesh:

Year:  2017        PMID: 28961382     DOI: 10.1002/nbm.3796

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.478


  6 in total

1.  Hyperpolarized MRI of Human Prostate Cancer Reveals Increased Lactate with Tumor Grade Driven by Monocarboxylate Transporter 1.

Authors:  Kristin L Granlund; Sui-Seng Tee; Hebert A Vargas; Serge K Lyashchenko; Ed Reznik; Samson Fine; Vincent Laudone; James A Eastham; Karim A Touijer; Victor E Reuter; Mithat Gonen; Ramon E Sosa; Duane Nicholson; YanWei W Guo; Albert P Chen; James Tropp; Fraser Robb; Hedvig Hricak; Kayvan R Keshari
Journal:  Cell Metab       Date:  2019-09-26       Impact factor: 27.287

2.  Absolute choline tissue concentration mapping for prostate cancer localization and characterization using 3D 1 H MRSI without water-signal suppression.

Authors:  Nassim Tayari; Alan J Wright; Arend Heerschap
Journal:  Magn Reson Med       Date:  2021-09-23       Impact factor: 3.737

3.  The prediction value of PI-RADS v2 score in high-grade Prostate Cancer: a multicenter retrospective study.

Authors:  Song Chen; Yun Yang; Tianchen Peng; Xi Yu; Haiqing Deng; Zhongqiang Guo
Journal:  Int J Med Sci       Date:  2020-05-30       Impact factor: 3.738

Review 4.  Radiomic and Genomic Machine Learning Method Performance for Prostate Cancer Diagnosis: Systematic Literature Review.

Authors:  Leandro Pecchia; Monica Franzese; Rossana Castaldo; Carlo Cavaliere; Andrea Soricelli; Marco Salvatore
Journal:  J Med Internet Res       Date:  2021-04-01       Impact factor: 5.428

Review 5.  Developments in proton MR spectroscopic imaging of prostate cancer.

Authors:  Angeliki Stamatelatou; Tom W J Scheenen; Arend Heerschap
Journal:  MAGMA       Date:  2022-04-20       Impact factor: 2.533

6.  Three-dimensional nuclear magnetic resonance spectroscopy: a complementary tool to multiparametric magnetic resonance imaging in the identification of aggressive prostate cancer at 3.0T.

Authors:  Michael Deal; Florian Bardet; Paul-Michael Walker; Mathilde Funes de la Vega; Alexandre Cochet; Luc Cormier; Imad Bentellis; Romaric Loffroy
Journal:  Quant Imaging Med Surg       Date:  2021-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.